英文字典中文字典


英文字典中文字典51ZiDian.com



中文字典辞典   英文字典 a   b   c   d   e   f   g   h   i   j   k   l   m   n   o   p   q   r   s   t   u   v   w   x   y   z       







请输入英文单字，中文词皆可：


请选择你想看的字典辞典：
单词字典翻译
387137查看　387137　在百度字典中的解释百度英翻中〔查看〕
387137查看　387137　在Google字典中的解释Google英翻中〔查看〕
387137查看　387137　在Yahoo字典中的解释Yahoo英翻中〔查看〕

安装中文字典英文字典查询工具!


中文字典英文字典工具:
选择颜色:
输入中英文单字

































































英文字典中文字典相关资料:


  • OPDIVO® OPDIVO Qvantig®
    OPDIVO Qvantig ® (nivolumab + hyaluronidase-nvhy) is a prescription medicine used alone as a first treatment for certain adults with kidney cancer that has spread (advanced renal cell carcinoma), after completing combination treatment with intravenous nivolumab and ipilimumab It is not known if OPDIVO Qvantig is safe and effective in children
  • Patient and Caregiver Stories | OPDIVO® OPDIVO Qvantig®
    The most common side effects observed with nivolumab given into the vein (intravenous nivolumab), which may be experienced with OPDIVO Qvantig, are shown below The most common side effects of intravenous nivolumab when used alone include: feeling tired or weak rash pain in muscles, bones, and joints itchy skin diarrhea nausea weakness cough
  • Frequently Asked Questions (FAQ) | OPDIVO® (nivolumab)
    Find answers to frequently asked questions about OPDIVO® (nivolumab) including what OPDIVO® is, how immunotherapy works, and what are the side effects of OPDIVO® Please see Indication and Important Safety Information
  • OPDIVO® Support Patient Resources | OPDIVO® (nivolumab)
    Whether you're a new or continuing OPDIVO® (nivolumab) patient, find resources that can support you through a cancer diagnosis and during treatment Access helpful resources and find assistance for OPDIVO® patients here Please see Indication and Important Safety Information
  • Classical Hodgkin Lymphoma (cHL) Cancer Treatment | OPDIVO® (nivolumab)
    OPDIVO® (nivolumab) is a treatment option for certain adults with previously treated classical Hodgkin lymphoma (cHL) whose cancer has come back or spread Please see Indication and Important Safety Information
  • How to Support a Loved One with Cancer | OPDIVO® (nivolumab)
    Learn about support resources designed to help you support yourself and your loved ones through a cancer diagnosis and during treatment Please see Indication and Important Safety Information
  • OPDIVO with You | Patient Caregiver Support Program Registration . . .
    Important Facts About OPDIVO Qvantig™ (nivolumab + hyaluronidase-nvhy) This is a summary of important information that you need to know about OPDIVO Qvantig Your healthcare team can work with you to help answer any questions you may have about this medication
  • Subcutaneous Injection Immunotherapy Treatment | OPDIVO Qvantig®
    Discover faster* administration with OPDIVO Qvantig ® (nivolumab + hyaluronidase-nvhy), an immunotherapy treatment given by injection that is FDA approved to treat most cancer types approved for OPDIVO ® (nivolumab)
  • Financial Information: Cost, Access Affordability | OPDIVO® (nivolumab)
    The most common side effects of intravenous nivolumab when used in combination with fluoropyrimidine and platinum-containing chemotherapy to treat esophageal cancer and gastric cancer include: nausea numbness, pain, tingling, or burning in your hands or feet decreased appetite feeling tired constipation mouth sores diarrhea vomiting
  • OPDIVO QVANTIG™ COULD BE YOUR ANSWER TO FASTER TREATME
    It’s important to talk to your doctor to discuss the most appropriate treatment for you OPDIVO Qvantig (nivolumab and hyaluronidase-nvhy) is FDA-approved, and may be an alternative option to intravenous (IV) OPDIVO® (nivolumab) for certain patients It is given through a subcutaneous (under-the-skin) injection OPDIVO Qvantig received by injection could be an option for people who are on





中文字典-英文字典  2005-2009